In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Protein Pathways Inc.

Latest From Protein Pathways Inc.

Start-Up Previews (07/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups feature companies involved in Congestive Heart Failure Devices, Pain Therapeutics, and Protein-Based Drug Discovery. Plus these selected Start-Ups across Health Care: Enanta Pharmaceuticals Inc., etrials Inc. and Organ Recovery Systems Inc.

Protein Pathways Inc.

Protein Pathways computationally analyzes and map protein-protein interactions. It both licenses out its data and is using the information as a principal tool for drug development.

BioPharmaceutical Research and Development Strategies

Downward Trends in Proteomics Deal Making

For more than a year, VCs have backed away from the proteomics tools group--drug companies hadn't signed the expected number and value of deals with them, and it was deal revenues that were, according to most business plans, going to support these start-ups. That pharma and biotech companies have a bigger appetite for products than for platform technology has become a truism. Licensors increasingly are finding that they must offer partners more than a discovery technology platform-either by validating targets and building value before out-licensing, or at least having the biological capability in-house to be a true collaborator.

BioPharmaceutical Strategy

Selected Start-Ups Founded in 2000 (1/00)

{In Vivo} summarizes the technologies of several medical companies founded within the last year. [Camitro Corp.] is developing computational models to predict ADME/PK properties of drug candidates. Researchers will be able to search for and purchase chemical compounds through []. Launched in September 1999, [Imetrx Inc.] is a cardiovascular interventional device company focused on locating and characterizing unstable coronary plaques that are responsible for atherosclerosis and acute cardiovascular events. Denmark's [NsGene A/S] is a joint venture of NeuroSearch A/S and the University of Lund. [Protein Pathways Inc.] aims to improve the speed and focus of drug development by determining functions for all genome-encoded proteins. [Trek Diagnostics Systems Inc.], a microbiology diagnostics testing company, was founded in January 1999 with the acquisition of the AccuMed International Inc.'s microbiology division.

See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Drug Discovery Tools
      • Bioinformatics
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Protein Pathways Inc.
  • Senior Management
  • Daniel Vapnek, PhD, CEO
    J. Christopher Griffin, VP, Bus. Dev.
    Matteo Pellegrini, Pres.
  • Contact Info
  • Protein Pathways Inc.
    Phone: (818) 340-2004
    21111 Oxnard St.
    Woodland Hills, CA 91367